volume 54 issue 5 pages 316-320

Heterocyclic NO prodrugs

Karl Schönafinger 1
1
 
HMR Research Chemistry, Frankfurt, Germany.
Publication typeJournal Article
Publication date1999-05-01
SJR
CiteScore
Impact factor
ISSN0014827X
Drug Discovery
Pharmaceutical Science
Abstract
An overview of the different heterocyclic NO-releasing compounds is given. Mesoionic heterocycles like sydnone imines are one example. This class is discussed on the synthesis and the mechanism of NO formation from Molsidomine and its first metabolite SIN-1. Furthermore, 1,2,3,4 oxatriazolium olates and imidates are presented in an example of the synthesis of GEA-3175. Heterocyclic N-oxides are another group of compounds capable of NO release under certain conditions. This class is discussed in the example of furoxane carboxamides like CAS-1609, and some SAR-data show the great impact of intramolecular hydrogen bridges on their in vitro activity. Each class of compounds requires different cofactors for NO release: sydnone imines need oxidants like oxygen, furoxanes are converted to NO via reaction with thioles.
Found 
Found 

Top-30

Journals

1
2
3
4
5
6
Mendeleev Communications
6 publications, 8.45%
Tetrahedron
3 publications, 4.23%
Russian Chemical Bulletin
3 publications, 4.23%
European Journal of Organic Chemistry
3 publications, 4.23%
Journal of Organic Chemistry
3 publications, 4.23%
Chemistry of Heterocyclic Compounds
2 publications, 2.82%
Advances in Heterocyclic Chemistry
2 publications, 2.82%
Tetrahedron Letters
2 publications, 2.82%
Journal of Organometallic Chemistry
2 publications, 2.82%
Bioorganic and Medicinal Chemistry
2 publications, 2.82%
Il Farmaco
2 publications, 2.82%
Chemical Reviews
2 publications, 2.82%
Annual Reports in Medicinal Chemistry
2 publications, 2.82%
Doklady Chemistry
1 publication, 1.41%
Journal of Medicinal Chemistry
1 publication, 1.41%
Journal of Molecular Structure
1 publication, 1.41%
Circulation Research
1 publication, 1.41%
Frontiers in Neuroscience
1 publication, 1.41%
Basic Research in Cardiology
1 publication, 1.41%
European Journal of Medicinal Chemistry
1 publication, 1.41%
Journal of Pharmaceutical and Biomedical Analysis
1 publication, 1.41%
Bioorganic and Medicinal Chemistry Letters
1 publication, 1.41%
Medicinal Research Reviews
1 publication, 1.41%
Fundamental and Clinical Pharmacology
1 publication, 1.41%
British Journal of Pharmacology
1 publication, 1.41%
Drug Development Research
1 publication, 1.41%
Cardiovascular Drug Reviews
1 publication, 1.41%
ChemInform
1 publication, 1.41%
Journal of Agricultural and Food Chemistry
1 publication, 1.41%
1
2
3
4
5
6

Publishers

5
10
15
20
25
Elsevier
21 publications, 29.58%
Wiley
11 publications, 15.49%
American Chemical Society (ACS)
9 publications, 12.68%
Springer Nature
7 publications, 9.86%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
6 publications, 8.45%
Taylor & Francis
5 publications, 7.04%
MDPI
4 publications, 5.63%
Royal Society of Chemistry (RSC)
2 publications, 2.82%
Pleiades Publishing
1 publication, 1.41%
Ovid Technologies (Wolters Kluwer Health)
1 publication, 1.41%
Frontiers Media S.A.
1 publication, 1.41%
Oxford University Press
1 publication, 1.41%
Walter de Gruyter
1 publication, 1.41%
5
10
15
20
25
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
71
Share
Cite this
GOST |
Cite this
GOST Copy
Schönafinger K. Heterocyclic NO prodrugs // Il Farmaco. 1999. Vol. 54. No. 5. pp. 316-320.
GOST all authors (up to 50) Copy
Schönafinger K. Heterocyclic NO prodrugs // Il Farmaco. 1999. Vol. 54. No. 5. pp. 316-320.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/S0014-827X(99)00031-2
UR - https://doi.org/10.1016/S0014-827X(99)00031-2
TI - Heterocyclic NO prodrugs
T2 - Il Farmaco
AU - Schönafinger, Karl
PY - 1999
DA - 1999/05/01
PB - Elsevier
SP - 316-320
IS - 5
VL - 54
PMID - 10418124
SN - 0014-827X
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{1999_Schönafinger,
author = {Karl Schönafinger},
title = {Heterocyclic NO prodrugs},
journal = {Il Farmaco},
year = {1999},
volume = {54},
publisher = {Elsevier},
month = {may},
url = {https://doi.org/10.1016/S0014-827X(99)00031-2},
number = {5},
pages = {316--320},
doi = {10.1016/S0014-827X(99)00031-2}
}
MLA
Cite this
MLA Copy
Schönafinger, Karl. “Heterocyclic NO prodrugs.” Il Farmaco, vol. 54, no. 5, May. 1999, pp. 316-320. https://doi.org/10.1016/S0014-827X(99)00031-2.